UNIVEST FINANCIAL Corp cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 7.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,384 shares of the semiconductor company’s stock after selling 2,552 shares during the quarter. UNIVEST FINANCIAL Corp’s holdings in Synopsys were worth $13,215,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of the stock. Elevation Wealth Partners LLC lifted its holdings in shares of Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 27 shares during the last quarter. North Dakota State Investment Board boosted its position in shares of Synopsys by 0.5% in the 3rd quarter. North Dakota State Investment Board now owns 5,706 shares of the semiconductor company’s stock valued at $2,482,000 after purchasing an additional 29 shares during the period. Oak Grove Capital LLC increased its stake in Synopsys by 1.1% in the 3rd quarter. Oak Grove Capital LLC now owns 2,898 shares of the semiconductor company’s stock worth $1,260,000 after purchasing an additional 32 shares in the last quarter. Kintegral Advisory LLC increased its stake in Synopsys by 0.6% in the 3rd quarter. Kintegral Advisory LLC now owns 5,812 shares of the semiconductor company’s stock worth $2,528,000 after purchasing an additional 32 shares in the last quarter. Finally, Centaurus Financial Inc. increased its stake in Synopsys by 2.6% in the 1st quarter. Centaurus Financial Inc. now owns 1,434 shares of the semiconductor company’s stock worth $569,000 after purchasing an additional 36 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts have issued reports on SNPS shares. UBS Group set a $570.00 price objective on Synopsys in a report on Thursday, August 27th. Zacks Research upgraded shares of Synopsys from a “hold” rating to a “strong-buy” rating in a report on Friday, October 2nd. Mizuho dropped their target price on shares of Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a research report on Thursday, August 27th. Sanford C. Bernstein began coverage on shares of Synopsys in a report on Friday, September 25th. They set an “outperform” rating on the stock. Finally, Robert W. Baird upgraded shares of Synopsys from a “neutral” rating to an “outperform” rating and lifted their price objective for the stock from $558.00 to $560.00 in a research report on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $575.00.
Read Our Latest Stock Analysis on SNPS
Insider Activity at Synopsys
In other news, CEO Sassine Ghazi sold 14,604 shares of the company’s stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $462.84, for a total value of $6,759,315.36. Following the transaction, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at approximately $35,576,196.60. This represents a 15.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the company’s stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the transaction, the chief financial officer directly owned 22,717 shares in the company, valued at $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 117,163 shares of company stock worth $51,366,457. Corporate insiders own 0.56% of the company’s stock.
Synopsys Price Performance
NASDAQ SNPS opened at $462.12 on Thursday. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The firm has a market capitalization of $88.56 billion, a price-to-earnings ratio of 46.74, a price-to-earnings-growth ratio of 1.46 and a beta of 1.18. The company has a 50 day simple moving average of $443.45 and a 200-day simple moving average of $441.55. Synopsys, Inc. has a 52-week low of $362.55 and a 52-week high of $539.48.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm’s revenue was up 42.4% on a year-over-year basis. During the same period in the previous year, the firm posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities research analysts predict that Synopsys, Inc. will post 11.01 earnings per share for the current fiscal year.
Synopsys announced that its board has initiated a share repurchase plan on Monday, October 5th that permits the company to repurchase $1 billion in outstanding shares. This buyback authorization permits the semiconductor company to buy up to 1.1% of its shares through open market purchases. Share buyback plans are often a sign that the company’s board believes its stock is undervalued.
Synopsys Company Profile
Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
See Also
- Five stocks we like better than Synopsys
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
